SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q4 2017 13F Holders as of 31 Dec 2017

Type / Class
Equity / COM
Total 13F shares
3,712,458
Share change
+278,525
Total reported value
$49,716,000
Price per share
$13.44
Number of holders
38
Value change
+$2,503,948
Number of buys
20
Number of sells
15

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q4 2017

As of 31 Dec 2017, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 38 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,712,458 shares. The largest 10 holders included BVF INC/IL, TIEDEMANN WEALTH MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, PARSONS CAPITAL MANAGEMENT INC/RI, Vanguard Group Inc, AXA, Alyeska Investment Group, L.P., Morse Asset Management, Inc, Sectoral Asset Management Inc, and C WorldWide Group Holding A/S. This page lists 38 institutional shareholders reporting positions in this security for the Q4 2017 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.